Stay updated on Nivolumab±Ipilimumab in Ovarian & Clear Cell Carcinomas Clinical Trial
Sign up to get notified when there's something new on the Nivolumab±Ipilimumab in Ovarian & Clear Cell Carcinomas Clinical Trial page.

Latest updates to the Nivolumab±Ipilimumab in Ovarian & Clear Cell Carcinomas Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe BrUOG 354 clinical trial record is displayed with its study details, eligibility criteria, locations, outcomes, and record history.SummaryDifference55%

- Check17 days agoChange DetectedThe footer revision label changed from v3.7.2 to v3.8.0. The study record area still displays a 403 Forbidden error.SummaryDifference0.2%

- Check24 days agoChange DetectedA site-wide NIH notice was added announcing updates and FAQs about terminology changes during the agency transition.SummaryDifference1%

- Check30 days agoChange DetectedThe footer revision number was updated from v3.7.1 to v3.7.2 while the page continued to display a 403 error.SummaryDifference0.2%

- Check37 days agoChange DetectedThe site revision label in the page footer changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check58 days agoChange DetectedRevision: v3.7.0 was added to the page, signaling a new revision of the study record. This update appears to be a maintenance/version update rather than a change to study details or results.SummaryDifference19%

Stay in the know with updates to Nivolumab±Ipilimumab in Ovarian & Clear Cell Carcinomas Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab±Ipilimumab in Ovarian & Clear Cell Carcinomas Clinical Trial page.